Alan G. Meehan

Statistics

Publications

Citations

2.1K

H-Index

Active since

1986

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Cornell University

The University of Texas Southwestern Medical Center

National Institute of Diabetes and Digestive and Kidney Diseases

University of Arkansas for Medical Sciences

Alan G. Meehan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, urology, and benign prostatic hyperplasia.

Publications per year

1986–2023

Publications

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

Vera H. Price, Janet L. Roberts, Maria Hordinsky et al. · Journal of the American Academy of Dermatology · 2000 · 296 citations

Medicine, Endocrinology, Pharmacotherapy +12

Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo

E. David Crawford, Shandra Wilson, John D. McConnell et al. · The Journal of Urology · 2006 · 235 citations

Medicine, Pharmacotherapy, Urology +12

Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects

Gary Herman, Arthur Bergman, Fang Liu et al. · The Journal of Clinical Pharmacology · 2006 · 185 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The Age Related Decrease in Testosterone is Significantly Exacerbated in Obese Men With the Metabolic Syndrome. What are the Implications for the Relatively High Incidence of Erectile Dysfunction Observed in These Men?

Steven A. Kaplan, Alan G. Meehan, Arvind Shah · The Journal of Urology · 2006 · 183 citations

Medicine, Endocrinology, Aging +16

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.

John F. Paolini, Yale Mitchel, Robert Reyes et al. · The American Journal of Cardiology · 2007 · 161 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

1–5 of 29